Published in J Cogn Neurosci on July 01, 2008
Cholinergic modulation of cognition: insights from human pharmacological functional neuroimaging. Prog Neurobiol (2011) 1.08
Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder. JAMA Psychiatry (2013) 1.02
Synergistic effects of genetic variation in nicotinic and muscarinic receptors on visual attention but not working memory. Proc Natl Acad Sci U S A (2009) 0.94
Cholinergic enhancement reduces functional connectivity and BOLD variability in visual extrastriate cortex during selective attention. Neuropharmacology (2012) 0.90
Dissociated mean and functional connectivity BOLD signals in visual cortex during eyes closed and fixation. J Neurophysiol (2012) 0.89
Cholinergic blockade under working memory demands encountered by increased rehearsal strategies: evidence from fMRI in healthy subjects. Eur Arch Psychiatry Clin Neurosci (2011) 0.86
Boosting visual cortex function and plasticity with acetylcholine to enhance visual perception. Front Syst Neurosci (2014) 0.85
Cholinergic modulation of visual working memory during aging: a parametric PET study. Brain Res Bull (2009) 0.84
Effects of acetylcholine on neuronal properties in entorhinal cortex. Front Behav Neurosci (2012) 0.83
Effect of cholinergic neurotransmission modulation on visual spatial paired associate learning in healthy human adults. Psychopharmacology (Berl) (2013) 0.79
Cholinergic control of visual categorization in macaques. Front Behav Neurosci (2011) 0.77
Cholinergic Potentiation of Restoration of Visual Function after Optic Nerve Damage in Rats. Neural Plast (2017) 0.75
A parametric study of prefrontal cortex involvement in human working memory. Neuroimage (1997) 5.34
Central cholinergic systems and cognition. Annu Rev Psychol (1997) 3.80
Working memory and language: an overview. J Commun Disord (2003) 3.28
Maintenance versus manipulation of information held in working memory: an event-related fMRI study. Brain Cogn (1999) 2.93
Prefrontal cortical contributions to working memory: evidence from event-related fMRI studies. Exp Brain Res (2000) 2.83
Dissociating working memory from task difficulty in human prefrontal cortex. Neuropsychologia (1997) 2.37
Cholinergic enhancement and increased selectivity of perceptual processing during working memory. Science (2000) 2.28
Neuromodulation and cortical function: modeling the physiological basis of behavior. Behav Brain Res (1995) 2.05
Neural correlates of cognitive efficiency. Neuroimage (2006) 2.01
Arousal systems and attentional processes. Biol Psychol (1997) 1.76
Dementia and working memory. Q J Exp Psychol A (1986) 1.70
Cholinergic modulation of the functional organization of the cat visual cortex. Brain Res (1983) 1.64
A functional role of cholinergic innervation to neurons in the cat visual cortex. J Neurophysiol (1987) 1.59
Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents. Neuroscience (2000) 1.43
Age-related changes in regional cerebral blood flow during working memory for faces. Neuroimage (1998) 1.42
Dissociating age-related changes in cognitive strategy and neural efficiency using event-related fMRI. Cortex (2005) 1.40
Cortical cholinergic transmission and cortical information processing in schizophrenia. Schizophr Bull (2005) 1.28
Effects of cholinergic enhancement on visual stimulation, spatial attention, and spatial working memory. Neuron (2004) 1.25
Selective effects of cholinergic modulation on task performance during selective attention. Neuropsychopharmacology (2007) 1.21
Effect of task difficulty on cerebral blood flow during perceptual matching of faces. Hum Brain Mapp (1996) 1.18
Cholinergic enhancement modulates neural correlates of selective attention and emotional processing. Neuroimage (2003) 1.18
Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2002) 1.14
Increased neural efficiency with repeated performance of a working memory task is information-type dependent. Cereb Cortex (2005) 1.07
Cholinergic enhancement of direction selectivity in the visual cortex of the cat. Neuroscience (1991) 1.07
Effects of attention and emotion on repetition priming and their modulation by cholinergic enhancement. J Neurophysiol (2003) 1.05
Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory. Proc Natl Acad Sci U S A (1997) 1.02
Selection and maintenance of stimulus-response rules during preparation and performance of a spatial choice-reaction task. Brain Res (2007) 0.98
Cholinergic pathways and the ascending reticular activating system of the human brain. Ann N Y Acad Sci (1995) 0.98
The effects of scopolamine on working memory in healthy young volunteers. Psychopharmacology (Berl) (1988) 0.93
The effects of novel cholinesterase inhibitors and selective muscarinic receptor agonists in tests of reference and working memory. Behav Brain Res (1993) 0.92
Pharmacological modulation of prefrontal cortical activity during a working memory task in young and older humans: a PET study with physostigmine. Am J Psychiatry (2005) 0.92
Cholinergic enhancement improves performance on working memory by modulating the functional activity in distinct brain regions: a positron emission tomography regional cerebral blood flow study in healthy humans. Brain Res Bull (2000) 0.91
Neural correlates of adjunctive rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind fMRI study. Neuroimage (2005) 0.90
Glycopyrrolate methobromide: 2. comparison with atropine sulphate in anaesthesia. Can Anaesth Soc J (1975) 0.87
Practice and difficulty evoke anatomically and pharmacologically dissociable brain activation dynamics. Cereb Cortex (2003) 0.87
Time course of pharmacodynamic and pharmacokinetic effects of physostigmine assessed by functional brain imaging in humans. Pharmacol Biochem Behav (2000) 0.86
Effect of AIT-082, a purine analog, on working memory in normal and aged mice. Pharmacol Biochem Behav (1994) 0.85
Effects of concomitant cholinergic and adrenergic stimulation on learning and memory performance by young and aged monkeys. Cereb Cortex (1993) 0.84
Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. Am J Psychiatry (2002) 3.20
Hypersensitivity to pain in congenital blindness. Pain (2013) 2.09
Brain fuel metabolism, aging, and Alzheimer's disease. Nutrition (2010) 1.89
Beyond sensory images: Object-based representation in the human ventral pathway. Proc Natl Acad Sci U S A (2004) 1.76
Adolescent behavior and dopamine availability are uniquely sensitive to dietary omega-3 fatty acid deficiency. Biol Psychiatry (2013) 1.67
Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder. Prostaglandins Leukot Essent Fatty Acids (2009) 1.54
Child neurology: hemiconvulsion-hemiplegia-epilepsy syndrome. Neurology (2012) 1.54
One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats. J Lipid Res (2005) 1.54
Dietary n-3 PUFA deprivation for 15 weeks upregulates elongase and desaturase expression in rat liver but not brain. J Lipid Res (2007) 1.48
Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry. Brain (2004) 1.45
Progression of corpus callosum atrophy in Alzheimer disease. Arch Neurol (2002) 1.44
Half-lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15 weeks of nutritional deprivation of n-3 polyunsaturated fatty acids. J Neurochem (2004) 1.42
Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231. Arch Neurol (2002) 1.41
Corticobasal syndrome associated with the A9D Progranulin mutation. J Neuropathol Exp Neurol (2007) 1.39
Reduced brain delivery of homovanillic acid to cerebrospinal fluid during human aging. Arch Neurol (2004) 1.39
Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease. Neurobiol Aging (2002) 1.35
Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients. Neurobiol Dis (2009) 1.35
Rat brain arachidonic acid metabolism is increased by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide. J Neurochem (2004) 1.33
Imaging neuroinflammation in Alzheimer's disease with radiolabeled arachidonic acid and PET. J Nucl Med (2008) 1.32
The effect of visual experience on the development of functional architecture in hMT+. Cereb Cortex (2007) 1.32
Brain elongation of linoleic acid is a negligible source of the arachidonate in brain phospholipids of adult rats. Biochim Biophys Acta (2006) 1.28
Regional network of magnetic resonance imaging gray matter volume in healthy aging. Neuroreport (2006) 1.27
Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats. Neuropsychopharmacology (2005) 1.26
Brain incorporation of 11C-arachidonic acid, blood volume, and blood flow in healthy aging: a study with partial-volume correction. J Nucl Med (2004) 1.25
Blood expression profiles for tuberous sclerosis complex 2, neurofibromatosis type 1, and Down's syndrome. Ann Neurol (2004) 1.25
Docosahexaenoic acid synthesis from alpha-linolenic acid by rat brain is unaffected by dietary n-3 PUFA deprivation. J Lipid Res (2007) 1.23
Age-related networks of regional covariance in MRI gray matter: reproducible multivariate patterns in healthy aging. Neuroimage (2009) 1.23
alpha-Linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid. J Neurochem (2005) 1.23
Characteristics of frontotemporal dementia patients with a Progranulin mutation. Ann Neurol (2006) 1.22
Selective effects of cholinergic modulation on task performance during selective attention. Neuropsychopharmacology (2007) 1.21
Beyond visual, aural and haptic movement perception: hMT+ is activated by electrotactile motion stimulation of the tongue in sighted and in congenitally blind individuals. Brain Res Bull (2010) 1.21
Relation of corpus callosum and hippocampal size to age in nondemented adults with Down's syndrome. Am J Psychiatry (2003) 1.19
Rapid high-energy microwave fixation is required to determine the anandamide (N-arachidonoylethanolamine) concentration of rat brain. Neurochem Res (2005) 1.19
Brain lipid metabolism in the cPLA2 knockout mouse. J Lipid Res (2003) 1.18
Formation of eicosanoids, E2/D2 isoprostanes, and docosanoids following decapitation-induced ischemia, measured in high-energy-microwaved rat brain. J Lipid Res (2008) 1.16
Chronic NMDA administration to rats up-regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein-2. J Neurochem (2007) 1.16
Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography. J Lipid Res (2008) 1.14
Upregulated liver conversion of alpha-linolenic acid to docosahexaenoic acid in rats on a 15 week n-3 PUFA-deficient diet. J Lipid Res (2006) 1.13
Chronic lithium administration attenuates up-regulated brain arachidonic acid metabolism in a rat model of neuroinflammation. J Neurochem (2007) 1.13
Differential modulation of neural activity throughout the distributed neural system for face perception in patients with Social Phobia and healthy subjects. Brain Res Bull (2008) 1.09
Rat heart cannot synthesize docosahexaenoic acid from circulating alpha-linolenic acid because it lacks elongase-2. J Lipid Res (2008) 1.09
Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans. Prostaglandins Leukot Essent Fatty Acids (2012) 1.09
The nature of consciousness in the visually deprived brain. Front Psychol (2011) 1.08
Brain incorporation of [11C]arachidonic acid in young healthy humans measured with positron emission tomography. J Cereb Blood Flow Metab (2002) 1.07
Chronic N-methyl-D-aspartate administration increases the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat. J Lipid Res (2007) 1.07
Beyond amygdala: Default Mode Network activity differs between patients with social phobia and healthy controls. Brain Res Bull (2009) 1.06
Brain lipid concentrations in bipolar disorder. J Psychiatr Res (2009) 1.06
Neuroinflammation and synaptic loss. Neurochem Res (2012) 1.06
Tactile flow explains haptic counterparts of common visual illusions. Brain Res Bull (2008) 1.05
Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and -2 in rat brain. J Neurochem (2003) 1.05
Screening for C9ORF72 repeat expansion in FTLD. Neurobiol Aging (2012) 1.05
New light from the dark: what blindness can teach us about brain function. Curr Opin Neurol (2011) 1.05
Cortical reorganization of language functioning following perinatal left MCA stroke. Brain Lang (2007) 1.04
Forgiveness, health, and well-being: a review of evidence for emotional versus decisional forgiveness, dispositional forgivingness, and reduced unforgiveness. J Behav Med (2007) 1.03
5-HT2A/2C receptor signaling via phospholipase A2 and arachidonic acid is attenuated in mice lacking the serotonin reuptake transporter. Psychopharmacology (Berl) (2005) 1.03
Imagery and spatial processes in blindness and visual impairment. Neurosci Biobehav Rev (2008) 1.02
Left-handedness and language lateralization in children. Brain Res (2011) 1.02
Selective remodeling of cardiolipin fatty acids in the aged rat heart. Lipids Health Dis (2006) 1.02
Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E₂ concentration in rat brain. J Neurochem (2011) 1.02
Recent studies on interactions between n-3 and n-6 polyunsaturated fatty acids in brain and other tissues. Curr Opin Lipidol (2002) 1.01
Imaging decreased brain docosahexaenoic acid metabolism and signaling in iPLA(2)β (VIA)-deficient mice. J Lipid Res (2010) 1.00
Decomposing metaphor processing at the cognitive and neural level through functional magnetic resonance imaging. Brain Res Bull (2011) 1.00
Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease. Am J Psychiatry (2002) 1.00
Chronic NMDA administration increases neuroinflammatory markers in rat frontal cortex: cross-talk between excitotoxicity and neuroinflammation. Neurochem Res (2008) 1.00
Distinct neural systems involved in agency and animacy detection. J Cogn Neurosci (2010) 1.00
Resting state brain glucose metabolism is not reduced in normotensive healthy men during aging, after correction for brain atrophy. Brain Res Bull (2004) 1.00
Retracted Whole-body synthesis-secretion rates of long-chain n-3 PUFAs from circulating unesterified alpha-linolenic acid in unanesthetized rats. J Lipid Res (2008) 1.00
Dietary n-6 PUFA deprivation for 15 weeks reduces arachidonic acid concentrations while increasing n-3 PUFA concentrations in organs of post-weaning male rats. Biochim Biophys Acta (2008) 0.99
Chronic lithium administration to rats selectively modifies 5-HT2A/2C receptor-mediated brain signaling via arachidonic acid. Neuropsychopharmacology (2005) 0.99
Lithium modifies brain arachidonic and docosahexaenoic metabolism in rat lipopolysaccharide model of neuroinflammation. J Lipid Res (2009) 0.99
Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder. Biol Psychiatry (2005) 0.99
Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain. Biol Psychiatry (2004) 0.98
Retracted Disturbed neurotransmitter transporter expression in Alzheimer's disease brain. J Alzheimers Dis (2011) 0.98
Imaging signal transduction via arachidonic acid in the human brain during visual stimulation, by means of positron emission tomography. Neuroimage (2006) 0.97
Retracted Imaging upregulated brain arachidonic acid metabolism in HIV-1 transgenic rats. J Cereb Blood Flow Metab (2010) 0.97
Analysis of gene expression with cDNA microarrays in rat brain after 7 and 42 days of oral lithium administration. Brain Res Bull (2002) 0.96
Chronic carbamazepine administration reduces N-methyl-D-aspartate receptor-initiated signaling via arachidonic acid in rat brain. Biol Psychiatry (2007) 0.96
Plasma free polyunsaturated fatty acid levels are associated with symptom severity in acute mania. Bipolar Disord (2007) 0.96
Do we really need vision? How blind people "see" the actions of others. J Neurosci (2009) 0.96
Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl-CoA by brain microsomal long-chain fatty acyl-CoA synthetases: relevance to bipolar disorder. Psychopharmacology (Berl) (2005) 0.96
Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231. Am J Psychiatry (2003) 0.95
Regulation of rat brain polyunsaturated fatty acid (PUFA) metabolism during graded dietary n-3 PUFA deprivation. Prostaglandins Leukot Essent Fatty Acids (2011) 0.95
Chronic lithium chloride administration to unanesthetized rats attenuates brain dopamine D2-like receptor-initiated signaling via arachidonic acid. Neuropsychopharmacology (2005) 0.94
Resting and arecoline-stimulated brain metabolism and signaling involving arachidonic acid are altered in the cyclooxygenase-2 knockout mouse. J Neurochem (2006) 0.94
D2 but not D1 dopamine receptor stimulation augments brain signaling involving arachidonic acid in unanesthetized rats. Psychopharmacology (Berl) (2005) 0.94